Amgen said to be near deal to buy Onyx for $10.5 billion

New York Times

Amgen is close to a deal to buy Onyx Pharmaceuticals Inc., a maker drugs to fight cancer, for about $10.5 billion, people briefed on the matter said on Saturday.Amgen Said to Be Near Deal to Buy Onyx for $10.5 Billion

Letter
to the
Editor

Send us a letter

Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

Recommended for You
Medicaid website 2
Deloitte's Medicaid systems criticized for widespread errors
oracle-hq-austin_i.jpg
Oracle, VA renew EHR contract for 11 months
Most Popular
1
UnitedHealthcare sues over Medicare Advantage ratings downgrade
2
What a Harris or Trump win means for the ACA, health insurance
3
CMS keeps raising the bar for Medicare Advantage star ratings
4
Why Labcorp, Quest Diagnostics are buying hospital labs
5
Humana plunges as Medicare star ratings drop threatens revenue